Search Results

Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers

Authors: Tomaka, F; Lefebvre, E; Sekar, V; Van Baelen, B; Vangeneugden, T; Vandevoorde, A; Diego Miralles, G

Source: HIV Medicine, Volume 10, Number 5, May 2009 , pp. 318-327(10)

Publisher: Blackwell Publishing

Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects: Phase I Randomized, Open-Label, Two-Way Crossover Study

Authors: Sekar, V.; Lefebvre, E.; De Marez, T.; De Pauw, M.; De Paepe, E.; Vangeneugden, T.; Hoetelmans, R.M.W.

Source: Clinical Drug Investigation, Volume 28, Number 8, 2008 , pp. 479-485(7)

Publisher: Adis International

Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers

Authors: Sekar, Vanitha J.; Lefebvre, Eric; De Pauw, Martine; Vangeneugden, Tony; Hoetelmans, Richard M.

Source: British Journal of Clinical Pharmacology, Volume 66, Number 2, August 2008 , pp. 215-221(7)

Publisher: Blackwell Publishing

The POWER and TITAN trials: darunavir/ritonavir in the management of HIV-infected patients

Author: Katlama, Christine

Source: Future HIV Therapy, Volume 2, Number 3, May 2008 , pp. 229-245(17)

Publisher: Future Medicine

Darunavir: In the Treatment of HIV-1 Infection

Authors: Fenton, Caroline; Perry, Caroline M.

Source: Drugs, Volume 67, Number 18, 2007 , pp. 2791-2801(11)

Publisher: Adis International

Darunavir (TMC114): a new HIV-1 protease inhibitor

Authors: Molina, Jean-Michel; Hill, Andrew

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 12, August 2007 , pp. 1951-1964(14)

Publisher: Informa Healthcare

Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers

Authors: Hoetelmans, Richard M. W.; Mariën, Kris; De Pauw, Martine; Hill, Andrew; Peeters, Monika; Sekar, Vanitha; De Doncker, Piet; Woodfall, Brian; Lefebvre, Eric

Source: British Journal of Clinical Pharmacology, Volume 64, Number 5, November 2007 , pp. 655-661(7)

Publisher: Blackwell Publishing

Clinical Pharmacokinetics of Darunavir

Authors: Rittweger, Michael; Arastéh, Keikawus

Source: Clinical Pharmacokinetics, Volume 46, Number 9, 2007 , pp. 739-756(18)

Publisher: Adis International

Pharmacokinetics of Darunavir (TMC114) and Atazanavir during Coadministration in HIV-Negative, Healthy Volunteers

Authors: Sekar, Vanitha J.; Lefebvre, Eric; Tine De Marez,; Spinosa-Guzman, Sabrina; Martine De Pauw,; Els De Paepe,; Vangeneugden, Tony; Hoetelmans, Richard M.W.

Source: Drugs in R&D, Volume 8, Number 4, 2007 , pp. 241-248(8)

Publisher: Adis International

Prediction of clinical benefits of ritonavir-boosted TMC114 from treatment effects on CD4 counts and HIV RNA

Authors: Hill, A; Montaner, J; Smith, C

Source: HIV Medicine, Volume 8, Number 4, May 2007 , pp. 234-240(7)

Publisher: Blackwell Publishing

Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials

Authors: Hill, A; Moyle, G

Source: HIV Medicine, Volume 8, Number 4, May 2007 , pp. 259-264(6)

Publisher: Blackwell Publishing

Screening and selecting for optimized antiretroviral drugs: rising to the challenge of drug resistance

Authors: de Béthune, Marie-Pierre; Hertogs, Kurt

Source: Current Medical Research and Opinion, Volume 22, Number 12, December 2006 , pp. 2603-2612(10)

Publisher: Informa Healthcare

On the Horizon: Promising Investigational Antiretroviral Agents

Authors: McNicholl, Ian R.; McNicholl, Joan J.

Source: Current Pharmaceutical Design, Volume 12, Number 9, March 2006 , pp. 1091-1103(13)

Publisher: Bentham Science Publishers